No human study has convincingly linked eating palm oil to developing cancer. Reviews of the available dietary evidence consistently reach the same conclusion: the data connecting palm oil consumption to cancer risk in people is thin and unconvincing. But the full picture is more layered than a simple “no.” A widely discussed mouse study found that palmitic acid, the main saturated fat in palm oil, can prime cancer cells to spread more aggressively. And the industrial refining process that turns crude palm oil into the clear, shelf-stable ingredient found in thousands of products generates chemical contaminants that are themselves classified as probable carcinogens. So the honest answer depends on which mechanism you’re asking about.
What Human Dietary Studies Show
When researchers have looked directly at whether people who eat more palm oil get cancer at higher rates, the answer has been consistently underwhelming. A 2019 review published in Nutrients stated plainly that there is no evidence associating palm oil consumption with higher cancer risk, incidence, or mortality in humans.1PubMed Central. Palm Oil on the Edge An earlier review in the International Journal of Food Sciences and Nutrition reached a similar conclusion, noting that specific studies on dietary palmitic acid or palm oil and cancer development are scarce and the evidence is not convincing.2PubMed. Palm oil and palmitic acid: a review on cardiovascular effects and carcinogenicity
That lack of evidence is worth putting in context. It does not mean palm oil has been thoroughly tested and cleared. It means few large-scale epidemiological studies have been designed specifically to isolate palm oil’s effect on cancer outcomes in humans. Palm oil is so ubiquitous in processed food that separating its contribution from the rest of someone’s diet is genuinely difficult. So when scientists say “no evidence of a link,” they’re being precise: the studies that would confirm or rule out a connection mostly haven’t been done, and the ones that exist don’t point toward harm.
The Mouse Study That Made Headlines
In 2021, a research team led by Salvador Aznar Benitah published a study in Nature that attracted enormous media attention. The researchers fed mice a short-term palm-oil-rich diet and found that dietary palmitic acid, the dominant fatty acid in palm oil, promoted metastasis in oral carcinomas and melanoma. More strikingly, the effect persisted even after the high-fat diet was removed. Tumor cells that had been briefly exposed to palmitic acid remained highly metastatic through several rounds of transplantation into new mice, with no further exposure to the fat.3PubMed. Dietary palmitic acid promotes a prometastatic memory via Schwann cells
The mechanism was specific to palmitic acid. Oleic acid (abundant in olive oil) and linoleic acid (found in many seed oils) did not have the same effect. The researchers traced the pro-metastatic “memory” to a fatty acid transporter called CD36 on the surface of cancer cells and to stable changes in how genes are read, specifically through modifications to a histone protein. In practical terms, the palmitic acid appeared to reprogram cancer cells at an epigenetic level, making them permanently better at recruiting surrounding cells to help tumors spread.4PubMed. Palmitic acid: Enabling the tumor’s nerves
This study was rigorous within its scope, but that scope was mice and lab-grown cancer cells, not people eating fried food. Mouse cancer models can reveal biological mechanisms, but the doses, delivery methods, and tumor biology don’t translate directly to human dietary exposure. The study also looked at whether palmitic acid helped existing tumors metastasize, not whether it caused new tumors to form. That distinction matters. Palm oil didn’t initiate cancer in these experiments; it turbocharged the spread of cancers that were already there. Whether the same thing happens in a human eating a normal diet remains unknown.
The CD36 Connection
The CD36 receptor from the mouse study is not a one-off curiosity. It has attracted broader attention as a player in how tumors use fatty acids. CD36 sits on the surface of many cell types and acts as a gateway for importing fats. In cancer biology, researchers have found that CD36 expression is associated with increased fatty acid uptake by tumor cells, and this uptake may fuel both tumor growth and the ability of cancer cells to spread. One line of research has shown that in liver cancer cells, CD36 activates a signaling chain that shifts cell metabolism toward a pattern that supports rapid growth.5Cell Death & Disease. The fatty acid receptor CD36 promotes HCC progression through activating Src/PI3K/AKT axis-dependent aerobic glycolysis
The idea is that some cancers essentially become fat-hungry, and palmitic acid happens to be one of the most common saturated fats in the human diet, whether it comes from palm oil, dairy, or meat. This raises a question the research hasn’t answered yet: is the issue palmitic acid specifically, or would any abundant dietary saturated fat have a similar effect in the right context? The mouse study pointed to something particular about palmitic acid, but broader tumor metabolism research suggests the CD36 pathway responds to fatty acids more generally.6PubMed Central. CD36-Fatty Acid-Mediated Metastasis via the Bidirectional Interactions of Cancer Cells and Macrophages For now, it’s an active area of investigation rather than a settled conclusion about diet.
Process Contaminants Are the Bigger Regulatory Concern
While the palmitic acid question plays out in labs, food safety regulators have zeroed in on a different problem: chemicals that form when palm oil is refined at high temperatures. Crude palm oil straight from the fruit is reddish and strongly flavored. To make it suitable for packaged foods, it goes through a process called deodorization, which involves heating the oil under vacuum. When temperatures climb above about 200°C, compounds called glycidyl esters begin forming from the oil’s natural diglycerides and monoglycerides.7Food Chemistry. Glycidyl esters in refined palm (Elaeis guineensis) oil and related fractions. Part I: Formation mechanism Formation accelerates sharply once temperatures pass about 230 to 240°C.8PubMed. Glycidyl esters in refined palm (Elaeis guineensis) oil and related fractions. Part II: practical recommendations for effective mitigation
A second family of contaminants, 3-MCPD esters, forms alongside glycidyl esters during the same refining process. Palm oil tends to have higher levels of both contaminants compared with other refined vegetable oils, largely because it requires more aggressive refining conditions and because its composition includes more of the precursor compounds that react at high heat.9PubMed Central. A Revisit to the Formation and Mitigation of 3-Chloropropane-1,2-Diol in Palm Oil Production
Why does this matter for cancer? When you digest glycidyl esters, your body releases glycidol, a small reactive molecule. In long-term animal studies, glycidol increased the incidence of tumors in several tissues of rats and mice, and the European Food Safety Authority concluded that the mechanism is likely genotoxic, meaning glycidol can damage DNA directly.10EFSA Journal. Risks for human health related to the presence of 3‐ and 2‐monochloropropanediol (MCPD), and their fatty acid esters, and glycidyl fatty acid esters in food Lab tests confirmed that glycidol itself triggers mutations in bacterial assays and causes structural chromosome damage in mammalian cells.11PubMed. Genotoxicity studies of glycidol fatty acid ester (glycidol linoleate) and glycidol The glycidyl esters themselves appear far less genotoxic; the concern is what they release once digested.
3-MCPD, the other main contaminant, is less clearly linked to cancer but has its own toxicity profile. EFSA set a tolerable daily intake of 2 micrograms per kilogram of body weight per day, based on kidney damage and effects on male fertility seen in rats.12PubMed Central. Update of the risk assessment on 3-monochloropropane diol and its fatty acid esters
Who Is Most at Risk from These Contaminants
For most adults eating a typical diet, exposure to glycidyl esters and 3-MCPD esters from palm oil falls within ranges that regulators consider manageable, if not entirely comfortable. The groups that raise red flags are infants and young children, largely because of infant formula. Vegetable fat blends used in formula often contain refined palm oil, and when you scale the exposure to a baby’s small body weight, the numbers climb quickly.
An Italian exposure assessment found that for infants, the intake of 3-MCPD from formula exceeded the tolerable daily intake by about 40 percent. The margin of exposure for glycidol in infants, toddlers, children, and adolescents consuming products like formula, biscuits, and chocolate spreads fell below the safety threshold regulators use as a benchmark, indicating a potential health concern.13PubMed. Food processing contaminants: Dietary exposure to 3-MCPD and glycidol and associated burden of disease for Italian consumers A study of dietary exposure in Shanghai found similar patterns: high-consuming infants and young children exceeded EFSA’s tolerable daily intake for 3-MCPD esters, with infant formula and biscuits as major contributors for younger age groups.14Journal of Food Composition and Analysis. Dietary exposure of general population to 3-monochloropropane-1, 2-diol esters from edible oils and oil-containing foods in Shanghai, China
In Singapore, estimated exposure for the general adult population sat at roughly half the tolerable daily intake, but high consumers reached about 110 percent of it. For glycidyl esters, the margins of exposure for both average and high-consuming adults fell below the safety threshold, which regulators flag as warranting attention.15PubMed Central. Occurrence and Dietary Exposure of 3-MCPD Esters and Glycidyl Esters in Domestically and Commercially Prepared Food in Singapore Among all food categories studied across multiple countries, refined fats and oils, particularly palm oil derivatives, consistently showed the highest contamination levels.16PubMed Central. Exposure to Dietary Glycidyl and 3-MCPD Fatty Acid Esters and Associated Burden of Cancer in Selected Asian and European Countries: A Review and Data Synthesis
How Refiners Are Reducing Contaminants
The palm oil industry has not ignored the problem. Since EFSA’s 2016 risk assessment drew public attention to glycidyl esters, both researchers and refiners have worked to bring contaminant levels down. The most effective single lever is temperature: keeping deodorization below 240°C cuts glycidyl ester formation dramatically. Optimizing several refining parameters together, including phosphoric acid dosage, degumming temperature, bleaching earth dosage, and deodorization temperature, has achieved reductions of more than 80 percent for 3-MCPD esters and roughly 65 percent for glycidyl esters without sacrificing the oil’s color or quality.17PubMed. Mitigation of 3-MCPD esters and glycidyl esters during the physical refining process of palm oil by micro and macro laboratory scale refining
At industrial scale, a combination of strategies has emerged. Washing crude palm oil before refining reduces 3-MCPD ester precursors. Using bleaching earth that hasn’t been activated with hydrochloric acid cuts another source. Double refining, where the oil goes through deodorization twice at lower temperatures instead of once at high heat, effectively targets glycidyl esters. No single fix addresses both families of contaminants simultaneously, so refiners typically stack multiple interventions.18Food Research International. Fatty acid esters of 3-monochloropropane-1,2-diol and glycidol in palm oil: A review on current industrial-scale mitigation strategies, challenges and perspectives European regulations now set maximum levels for glycidyl esters in vegetable oils and fats, and the industry has responded with measurable declines in contamination over the past several years. Infant formula receives the strictest limits.
Repeated Frying Makes Things Worse
Even when refined palm oil starts out with acceptable contaminant levels, what happens in the kitchen or the commercial fryer matters. Heating any cooking oil repeatedly causes a cascade of chemical changes: oxidation, hydrolysis, and polymerization. The oil darkens, thickens, and accumulates breakdown products like peroxides and aldehydes that get absorbed into fried food.19Arabian Journal of Chemistry. The effect of repetitive frying on physicochemical properties of refined, bleached and deodorized Malaysian tenera palm olein during deep-fat frying Some of these breakdown products are themselves implicated in cellular damage and inflammation, though the link to cancer in humans at typical dietary levels remains uncertain.
Research on palm kernel oil specifically found that quality deteriorated beyond the acceptable safety limit for peroxide value by the third frying cycle, leading the authors to recommend that the oil should not be reused after the second frying.20Food Safety and Health. Thermal Degradation and Safety of Repeatedly Heated Palm Kernel Oil During Deep Frying This is relevant for street food vendors and restaurants in tropical countries where palm oil is the default frying medium and cost pressures encourage reuse. The cancer-relevant question with repeated frying is less about palm oil in particular and more about the universal chemistry of abusing any cooking oil, but palm oil’s widespread use in commercial frying means it accounts for a large share of the exposure in practice.
Effects on the Gut
A separate line of research has looked at what palm oil does to the intestinal lining. In mouse experiments, even a few oral doses of palm oil increased intestinal permeability, meaning the gut barrier became leakier. The mechanism involved disruption of the proteins that hold gut cells tightly together. The same exposures shifted the composition of gut bacteria, reducing populations of beneficial species, and ramped up inflammatory signaling in the intestinal tissue.21PubMed. Palmitic acid damages gut epithelium integrity and initiates inflammatory cytokine production
A leaky gut and chronic low-grade inflammation are associated in broader research with increased susceptibility to various diseases, including some cancers. But as with the metastasis study, these are animal findings that used concentrated doses, and extrapolating to human diets requires caution. The gut microbiome research adds another layer of biological plausibility to the idea that high palm oil consumption could have health consequences, without providing direct evidence that it causes cancer in people.
The Paradox of Palm Oil’s Anti-Cancer Compounds
Here is where the story gets genuinely strange. Crude, unrefined palm oil is one of the richest natural sources of tocotrienols, a form of vitamin E that has shown striking anti-cancer properties in laboratory settings. The tocotrienol-rich fraction of palm oil has been shown to inhibit cell growth and trigger programmed cell death in colon carcinoma cells through activation of the p53 tumor-suppressor pathway.22PubMed. Tocotrienol-rich fraction of palm oil activates p53, modulates Bax/Bcl2 ratio and induces apoptosis independent of cell cycle association Lab and animal studies have found that tocotrienols can suppress tumor growth, block the formation of new blood vessels that feed tumors, and inhibit metastasis across several cancer types including breast, colorectal, pancreatic, prostate, and liver cancers.23Multitech Journal of Science and Technology. Palm Oil Tocotrienols in Cancer Chemoprevention and Therapy: Molecular Targets, Selectivity, and Clinical Translation
What makes tocotrienols especially interesting is their apparent selectivity: in cell culture, they kill cancer cells while leaving normal cells largely unharmed. This has led some researchers to investigate them as potential adjuncts to cancer treatment. But there’s a practical catch. Most of the refined palm oil in processed food has been stripped of its tocotrienols and carotenoids during processing. The very refining steps that create glycidyl esters and 3-MCPD also remove many of the bioactive compounds that might be protective. So the palm oil in your cookies and your margarine is chemically quite different from crude palm oil or the concentrated tocotrienol extracts used in lab experiments. The anti-cancer findings are real at the cellular level but may have limited relevance to how most people actually encounter palm oil.
What a Consumer Can Reasonably Do
If you eat a typical Western or Southeast Asian diet, you’re consuming palm oil regularly whether you realize it or not. It’s in baked goods, instant noodles, ice cream, margarine, chocolate, infant formula, and cosmetics. Eliminating it entirely is impractical for most people, and the evidence doesn’t suggest you need to.
The most grounded concerns center on process contaminants, not the oil’s fatty acid profile. A few practical steps reduce your exposure:
- Infant formula: If you’re choosing formula for a baby, look for brands that specifically state reduced glycidyl ester or 3-MCPD levels. European regulations have driven reformulation, but products vary.
- Reused frying oil: Avoid food fried in oil that’s been reheated many times. If you deep-fry at home with palm oil, replace it after one or two uses rather than topping it off repeatedly.
- Processed snack foods: Biscuits, chocolate spreads, and similar products made with refined palm oil are among the higher-exposure items, particularly for children. Moderating these is sensible for multiple nutritional reasons beyond contaminant exposure.
Switching entirely to another vegetable oil is not a guaranteed solution, either. Other oils also form glycidyl esters during refining, just typically at lower levels. And every cooking oil has its own profile of heat-generated compounds when used for frying. The issue is less about palm oil as a uniquely dangerous substance and more about the chemistry that happens whenever fats meet high heat in industrial processing or repeated kitchen use.
Why the Science Feels Contradictory
Part of the confusion around palm oil and cancer comes from the fact that researchers are studying several different things under the same umbrella question. The palmitic-acid-and-metastasis findings are about tumor biology and fat metabolism in mice. The process contaminant findings are about industrial chemistry and toxicology. The tocotrienol findings are about plant biochemistry and isolated compounds in cell culture. The human dietary reviews are about population-level eating patterns and disease rates. These are different fields asking different questions with different methods, and they don’t all point in the same direction.
What can be said with reasonable confidence is that eating palm oil in ordinary amounts does not appear to cause cancer in humans based on the evidence currently available. What is also clear is that the refining process creates contaminants that are genuinely genotoxic in animals, that some populations, especially infants and young children, are exposed at levels that exceed safety thresholds, and that the industry is actively working to bring those levels down. The palmitic acid research raises legitimate biological questions about how dietary fats interact with existing tumors, but translating mouse experiments to human dietary advice requires far more evidence than currently exists.